# Lysoway Therapeutics

**Source:** https://www.startuphub.ai/startups/lysoway-therapeutics
**Profile type:** Startup

> Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

## About

Lysoway Therapeutics is a biopharmaceutical company focused on developing novel small-molecule therapies that modulate lysosomal ion channels. Their primary focus is on addressing neurodegenerative diseases, with a specific program targeting TMEM175 agonists for Parkinson's disease, supported by grants from The Michael J. Fox Foundation for Parkinson's Research.

## Key facts

- **Slug:** lysoway-therapeutics
- **Website:** https://www.lysowaytherapeutics.com/
- **Location:** Cambridge, Massachusetts, USA
- **Founded:** 2021-01-01T00:00:00
- **Operating status:** Inactive
- **Total funding:** $45M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Neuroscience, Biotech, Drug Discovery, Neurodegenerative Diseases, Small Molecule Therapeutics, Lysosomal Ion Channels, Parkinson's Disease
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/lysoway-therapeutics/

## Frequently asked

### What does Lysoway Therapeutics do?

Lysoway Therapeutics is a biopharmaceutical company focused on developing novel small-molecule therapies that modulate lysosomal ion channels. Their primary focus is on addressing neurodegenerative diseases, with a specific program targeting TMEM175 agonists for Parkinson's disease, supported by grants from The Michael J. Fox Foundation for Parkinson's Research.

### What is Lysoway Therapeutics's revenue?

StartupHub estimates Lysoway Therapeutics's annual revenue at $65.9M (range $36.1M to $170.5M, 44% confidence), based on comparable companies in the sector.

### What is Lysoway Therapeutics's valuation?

StartupHub estimates Lysoway Therapeutics's effective valuation at $732.8M (range $513.0M to $952.6M, 30% confidence), based on comparable companies in the sector.

### How much funding has Lysoway Therapeutics raised?

Lysoway Therapeutics has raised a total of $45M in funding. The most recent round on record is Series A.

### Where is Lysoway Therapeutics headquartered?

Lysoway Therapeutics is headquartered in Cambridge, Massachusetts, USA.

### When was Lysoway Therapeutics founded?

Lysoway Therapeutics was founded in 2021.

### What industry does Lysoway Therapeutics operate in?

Lysoway Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Neuroscience, Biotech, Drug Discovery.

### What is Lysoway Therapeutics's current status?

Lysoway Therapeutics's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Lysoway Therapeutics",
          "item": "https://www.startuphub.ai/startups/lysoway-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/lysoway-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/lysoway-therapeutics",
      "name": "Lysoway Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Lysoway Therapeutics. Lysoway Therapeutics is a startup founded in 2021, operating in Biotechnology and Pharmaceuticals. Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, USA.",
      "dateModified": "2026-07-07T14:52:50.374285+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/lysoway-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/lysoway-therapeutics#organization",
      "name": "Lysoway Therapeutics",
      "url": "https://www.lysowaytherapeutics.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/854ac7f9-beaa-4b74-acfb-dbae49ced507-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/854ac7f9-beaa-4b74-acfb-dbae49ced507-square.webp",
      "description": "This is the official profile of Lysoway Therapeutics. Lysoway Therapeutics is a startup founded in 2021, operating in Biotechnology and Pharmaceuticals. Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, USA.",
      "sameAs": [
        "https://www.linkedin.com/company/lysoway-therapeutics/",
        "https://www.startuphub.ai/startups/lysoway-therapeutics"
      ],
      "foundingDate": "2021-01-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "Massachusetts",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare",
        "Neuroscience",
        "Biotech",
        "Drug Discovery",
        "Neurodegenerative Diseases",
        "Small Molecule Therapeutics",
        "Lysosomal Ion Channels",
        "Parkinson's Disease"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/lysoway-therapeutics#profile-assessment",
      "name": "Lysoway Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/lysoway-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/854ac7f9-beaa-4b74-acfb-dbae49ced507-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of Lysoway Therapeutics. Lysoway Therapeutics is a startup founded in 2021, operating in Biotechnology and Pharmaceuticals. Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, USA.",
      "brand": {
        "@type": "Brand",
        "name": "Lysoway Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-07",
        "name": "Lysoway Therapeutics - Profile Score 48/100",
        "reviewBody": "This is the official profile of Lysoway Therapeutics. Lysoway Therapeutics is a startup founded in 2021, operating in Biotechnology and Pharmaceuticals. Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, USA.",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 48,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```